Author:
Prieto de Paula José María,Martín-Luquero Ibáñez Miguel,Franco Hidalgo Silvia
Reference5 articles.
1. International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: a 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases;Gupta;Clin Infect Dis,2011
2. Hépatite auto-immune induite par la nitrofurantoïne: une complication rare à connaître;Sorin;Rev Med Intern,2016
3. Features of autoimmune hepatitis in patients with drug-induced liver injury;de Boer;Clin Gastroenterol Hepatol,2017
4. Restriction d’utilisation en raison d’un risqué de survenue d’effets indesirables graves hepatiques et pulmonaires. Available from: http://ansm.sante.fr/S-informer/Informations-de-securite-Lettres-aux-professionnels-de-sante/Nitrofurantoine [accessed 7.11.16].
5. Nitrofurantoína (Furantoína®): nuevas restricciones de uso. Available from: https://www.aemps.gob.es/informa/notasInformativas/medicamentosUsoHumano/seguridad/2016/NI-MUH_FV_16-nitrofurantoina.htm [accessed 2.12.16].